Company intelligence / Profile preview

Enzis

Groningen, Groningen, Netherlands

Ownership: Private
Development stage: Other

Overview

Enzis is a specialized biotechnology contract research organization (CRO) focused on the field of biocatalysis. Founded as a spin-off from the University of Groningen, the company develops advanced enzymatic processes for the production of chiral intermediates and active pharmaceutical ingredients (APIs). Enzis provides a range of services including enzyme screening, process development, and the supply of specialized biocatalysts to the pharmaceutical and fine chemical industries. By leveraging nature's catalysts, the company enables more sustainable and cost-effective manufacturing routes for complex organic molecules.

Modalities: EnzymesSmall molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Enzis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enzis.

Explore the full profile